written on 21.03.2014
Tags:
,

Off-label Avastin in AMD: the European Commission gets involved

TAGS: ,

The controversy over the off-label use of Roche's Avastin (bevacizumab) in wet AMD has spread beyond national borders and is now on the EU agenda, after the European Commission said it was planning to launch a study of off-label prescribing to better…

Latest Report